首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1739586

軟膠囊市場按材料、應用和地區分類（2026-2032 年）

Softgel Capsules Market By Material (Gelatin, Non-Gelatin), Application (Pharmaceutical, Nutraceuticals), & Region for 2026-2032

出版日期: 2025年05月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

軟膠囊市場評估（2026-2032）

消費者健康意識的不斷提升推動了軟膠囊的普及。藥物配方的進步也提升了其對新型治療方法的吸引力，推動其市場規模在2024年突破38.2億美元，到2032年估值將達到約58.4億美元。

除此之外，自然療法的趨勢正在刺激軟膠囊的採用，軟膠囊通常具有更高的生物利用度，從而更有效地輸送營養，因此該市場在 2026 年至 2032 年期間的複合年成長率將達到 5.46%。

軟膠囊市場定義/概述

軟膠囊是一種將液體、油類或活性成分封裝在明膠基殼中的給藥系統。這種獨特的設計使其易於吞嚥並快速溶解，從而實現膠囊內物質的有效吸收。軟膠囊有多種尺寸，可與多種成分配製，包括維生素、草藥萃取物和藥物。

軟膠囊的應用範圍廣泛，涵蓋製藥、營養保健品和化妝品行業。在製藥領域，它們用於遞送需要精準劑量和快速生物利用度的藥物。在營養保健品領域，軟膠囊作為膳食補充品廣受歡迎，為消費者提供獲取日常生活所需營養的便利途徑。此外，軟膠囊也用於化妝品中，用於包覆油脂和活性成分，從而提高產品的穩定性和功效。

對膳食補充劑和營養食品日益成長的需求將如何促進軟膠囊的採用？

膳食補充劑和營養食品需求的不斷成長是軟膠囊市場的主要驅動力。根據美國食品藥物管理局) 的數據，約 75% 的美國服用膳食補充劑，其中許多人喜歡軟膠囊，因為它易於吞嚥且生物利用度更高。這一趨勢推動了軟膠囊技術的產量成長和創新。 2023 年 7 月，領先的軟膠囊製造商 Catalent 宣布擴大其在義大利的軟膠囊產能，以滿足全球日益成長的需求，尤其是膳食補充劑的需求。

全球人口老化及其引發的慢性病發病率上升正在推動製藥業的成長，從而刺激軟膠囊市場的發展。根據世界衛生組織（WHO）的報告，2015年至2050年期間，全球60歲及以上人口的比例將幾乎加倍，從12%增加到22%。這種人口結構變化促使製藥公司開發更容易服用的給藥方式。 2023年8月，仙樂製藥推出了一項新的植物來源軟膠囊技術，以滿足老年消費者對素食和純素藥物日益成長的需求。

消費者對天然和有機產品的日益成長的偏好推動了素食軟膠囊的創新。美國農業部報告稱，2020年有機食品和非食品產品的銷售額將達到6,19億美元，顯示天然替代品市場蓬勃發展。這一趨勢也延伸到了製藥和營養保健品產業，軟膠囊製造商正在努力開發新的配方。 2023年9月，龍沙旗下Capsugel公司推出了一系列以木薯澱粉為基礎的素食軟膠囊，以滿足軟膠囊市場對潔淨標示和無過敏原產品日益成長的需求。

軟膠囊的穩定性和保存期限問題是否會限制其使用？

軟膠囊市場正面臨諸多限制因素，可能阻礙其成長。其中一項關鍵挑戰是軟膠囊生產成本高。生產所需的專用設備和材料導致價格上漲，中小企業和新參與企業難以負擔。

另一個限制因素是潛在的穩定性和儲存問題。某些活性成分在軟膠囊製劑中可能無法保持穩定，這限制了能夠以軟膠囊製劑有效遞送的產品類型。這種擔憂可能會促使製造商尋求能夠為敏感化合物提供更高穩定性的替代遞送系統。

監管障礙也給軟膠囊市場帶來了挑戰。膳食補充劑和藥品的核准流程可能漫長而複雜，尤其是在監管嚴格的地區。這可能會減緩新軟膠囊產品的上市速度，並阻礙企業對這種給藥方式的投資。

Increasing health consciousness among consumers is propelling the adoption of softgel capsules. Advancements in drug formulations enhance the appeal of softgel capsules for new therapies and are driving the market size to surpass USD 3.82 Billion in 2024 to reach a valuation of around USD 5.84 Billion by 2032.

In addition to this, the trend toward natural remedies is spurring up the adoption of softgel capsules. Softgel capsules often offer improved bioavailability, leading to more effective nutrient delivery is enabling the market to grow at a CAGR of 5.46% from 2026 to 2032.

Softgel Capsules Market: Definition/ Overview

Softgel capsules are a form of dosage delivery system that encapsulates liquids, oils, or active ingredients within a gelatin-based shell. This unique design allows for easy swallowing and quick dissolution, enabling efficient absorption of the encapsulated substances. Softgels are available in various sizes and can be formulated to contain a wide range of ingredients, including vitamins, herbal extracts, and pharmaceuticals.

The applications of softgel capsules are diverse, spanning the pharmaceutical, nutraceutical, and cosmetic industries. In pharmaceuticals, they are used to deliver medications that require precise dosing and rapid bioavailability. In the nutraceutical sector, softgels are popular for dietary supplements, offering consumers an easy way to incorporate essential nutrients into their daily routines. Additionally, softgels are used in cosmetics for encapsulating oils and active ingredients, enhancing product stability and effectiveness.

How will Rising Demand for Nutraceuticals and Dietary Supplements Increase Adoption of Softgel Capsules?

The rising demand for nutraceuticals and dietary supplements has been a significant driver of the softgel capsules market. According to the U.S. Food and Drug Administration, about 75% of Americans take dietary supplements, with many preferring softgel capsules for their ease of swallowing and improved bioavailability. This trend has led to increased production and innovation in softgel technology. In July 2023, Catalent, a leading softgel manufacturer, announced the expansion of its softgel manufacturing capacity in Italy to meet growing global demand, particularly for nutraceutical products.

An aging global population and the associated increase in chronic diseases have fueled the growth of the pharmaceutical sector, consequently boosting the softgel capsules market. The World Health Organization reported that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. This demographic shift has spurred pharmaceutical companies to develop more easily consumable drug delivery forms. In August 2023, Sirio Pharma unveiled a new plant-based softgel technology, catering to the growing demand for vegetarian and vegan-friendly medication options among older consumers.

The increasing consumer preference for natural and organic products has driven innovation in plant-based softgel capsules. The U.S. Department of Agriculture reported that sales of organic food and non-food products reached USD 61.9 Billion in 2020, indicating a strong market for natural alternatives. This trend has extended to the pharmaceutical and nutraceutical industries, prompting softgel manufacturers to develop new formulations. In September 2023, Capsugel, a Lonza company, launched a new line of plant-based softgel capsules made from tapioca starch, addressing the growing demand for clean-label and allergen-free products in the softgel market.

Will Stability and Shelf-Life Issues of Softgel Capsules Restrain Its Application?

The softgel capsules market faces several restraints that may impede its growth. One significant challenge is the high production costs associated with manufacturing softgel capsules. The specialized equipment and materials required for their production can lead to increased prices, making it less accessible for smaller companies and new entrants in the market.

Another restraint is the potential for stability and shelf-life issues. Some active ingredients may not remain stable within softgel formulations, which can limit the types of products that can be effectively delivered in this form. This concern may lead manufacturers to seek alternative delivery systems that offer better stability for sensitive compounds.

Regulatory hurdles also pose challenges to the softgel market. The approval processes for dietary supplements and pharmaceuticals can be lengthy and complex, particularly in regions with stringent regulations. This can slow down the introduction of new softgel products and deter companies from investing in this delivery format.

Category-Wise Acumens

Will Gelatin Segment Hold Major Share in Softgel Capsules Market?

Gelatin continues to dominate the softgel capsules market due to its unique properties and widespread acceptance in the pharmaceutical industry. According to the U.S. Food and Drug Administration's Inactive Ingredient Database, gelatin is listed in over 1,000 approved drug products as of 2023, highlighting its prevalence in pharmaceutical formulations. This widespread use is attributed to gelatin's excellent oxygen barrier properties, compatibility with a wide range of fill materials, and cost-effectiveness. In July 2023, Rousselot, a leading gelatin manufacturer, announced the launch of a new pharmaceutical-grade gelatin specifically designed for softgel applications, promising enhanced stability and performance.

The superior dissolution profile of gelatin-based softgels contributes significantly to their dominance in the market. The European Medicines Agency reported in 2022 that over 60% of approved oral drug products in the EU used gelatin as a primary excipient, with softgel capsules representing a substantial portion. This preference is driven by gelatin's ability to dissolve rapidly at body temperature, ensuring quick release of active ingredients. Recognizing this advantage, Catalent Pharma Solutions introduced a new gelatin-based technology in August 2023 that allows for controlled release of drugs from softgel capsules, expanding the application of gelatin in advanced drug delivery systems.

Which Factors Enhance the Use of Softgel Capsules in Nutraceutical Sector?

The nutraceutical sector has emerged as a dominant force in the softgel capsules market, driven by increasing consumer focus on preventive healthcare and wellness. According to the U.S. National Institutes of Health, over 170 million Americans take dietary supplements regularly, with softgel capsules being a preferred delivery form for many nutraceutical products. This widespread adoption has led to significant market growth and innovation. In August 2023, Nature's Bounty, a leading nutraceutical company, introduced a new line of softgel supplements featuring enhanced absorption technology, catering to the growing demand for more effective nutraceutical products.

The versatility of softgel capsules in encapsulating a wide range of nutraceutical ingredients has contributed to their popularity in this sector. The European Food Safety Authority reported in 2022 that softgel capsules accounted for approximately 40% of all new nutraceutical product launches in the EU. This preference is due to softgels' ability to mask unpleasant tastes and odors while providing improved bioavailability for many compounds. Capitalizing on this trend, in July 2023, Lonza announced the expansion of its softgel manufacturing capabilities, specifically targeting the growing demand for complex nutraceutical formulations.

Gain Access into Softgel Capsules Market Report Methodology

Country/Region-wise Acumens

Will Robust Pharmaceutical Industry in North America Drive Softgel Capsules Market Growth?

North America is establishing itself as the dominant region in the softgel capsules market, driven by a robust pharmaceutical industry and high consumer demand for dietary supplements. According to the U.S. Food and Drug Administration, approximately 75% of Americans take dietary supplements, with softgel capsules being a popular choice due to their ease of swallowing and improved absorption. This high consumption rate has led to significant market growth and innovation. In July 2023, Catalent, a leading contract development and manufacturing organization, announced a USD 350 Million investment to expand its softgel manufacturing capabilities in Kentucky, reinforcing North America's position in the market.

The region's dominance is further strengthened by its advanced healthcare infrastructure and stringent quality standards. The U.S. National Institutes of Health reported that in 2022, over 60% of clinical trials involving oral drug formulations utilized softgel capsules, highlighting their importance in pharmaceutical development. This prevalence has attracted substantial investment from key players. In August 2023, Sirio Pharma, a global nutraceutical contract development and manufacturing organization, opened a new R&D center in California focused on developing innovative softgel technologies for both pharmaceutical and nutraceutical applications.

Will Rising Healthcare Expenditure Enhance Adoption of Softgel Capsules in Asia Pacific?

The Asia Pacific region is experiencing rapid growth in the softgel capsules market, driven by increasing healthcare expenditure and a growing awareness of preventive healthcare. According to China's National Medical Products Administration, the number of approved softgel capsule formulations increased by 28% between 2020 and 2022, reflecting the rising demand for this delivery form. This growth has attracted significant investment from global players. In August 2023, Catalent announced the expansion of its softgel manufacturing facility in Japan, doubling its production capacity to meet the increasing regional demand for both pharmaceutical and nutraceutical softgel products.

India has emerged as a key contributor to the region's market growth, with its large pharmaceutical manufacturing base. The Indian Ministry of Commerce and Industry reported that pharmaceutical exports, including softgel capsules, grew by 18% in the fiscal year 2022-23 compared to the previous year. This growth has spurred innovation in the sector. In July 2023, ACG Group, a leading Indian pharmaceutical supplier, launched a new range of vegetarian softgel capsules made from plant-based materials, catering to the growing demand for vegetarian options in the Asian market.

Competitive Landscape

The softgel capsules market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the softgel capsules market include:

Capsugel (Lonza)
Aenova Group
EuroCaps
Catalent
Soft Gel Technologies, Inc.
Herbalife
C3S
Fuisz Pharma
Amgen
Pfizer
GlaxoSmithKline
Nature's Way
DSM Nutritional Products
Bausch Health
Pharmavite LLC
Shionogi
NBTY
Tishcon Corp
Omega Protein Corporation
JRS Pharma

Latest Developments

In September 2023, a major manufacturer in the softgel capsules market announced the launch of a new line of plant-based softgels, catering to the growing demand for vegan and clean-label products.
In August 2023, a leading research firm released a report forecasting a CAGR of 6.5% for the softgel capsules market through 2030, driven by increasing consumer preference for dietary supplements and pharmaceuticals.